This manuscript uses the BRAVATO template to report the key considerations for a benefit-risk assessment of the coronavirus diseas...

This paper uses a BRAVATO protein template to review the features of Novavax’s recombinant adjuvanted spike protein vaccine to p...

Replication-incompetent adenoviral vectors have been under investigation as a platform to carry a variety of transgenes, and exp...

The Modified Vaccinia Ankara (MVA) vector system is being explored as a platform for development of multiple vaccines. This pape...

The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) was formed to evaluate the safety and other...

This paper uses the BRAVATO inactivated virus vaccine template to review the features of an inactivated whole chikungunya virus...

This paper uses a BRAVATO nucleic acid template to review the features of Moderna’s rapid-response proprietary vaccine platform...

Auro Vaccines LLC has developed a protein vaccine to prevent disease from Nipah and Hendra virus infection that employs a recomb...

This tool was aimed at identifying potential major hurdles or gaps that would need to be addressed during the development of vecto...